Skip to main content
BEONE MEDICINES LTD. logo

BEONE MEDICINES LTD. — Investor Relations & Filings

Ticker · 688235 ISIN · CNE100005XT6 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 727 across all filing types
Latest filing 2025-04-15 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 688235

About BEONE MEDICINES LTD.

https://beonemedicines.com/

BEONE MEDICINES LTD. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutic solutions, primarily in the field of oncology. The company specializes in the discovery of targeted small molecule drugs and biologics designed to address unmet medical needs in cancer treatment. Its research and development pipeline emphasizes precision medicine, utilizing advanced molecular biology and medicinal chemistry platforms to identify novel drug candidates. BEONE MEDICINES LTD. aims to improve patient outcomes by developing high-efficacy, low-toxicity therapies that target specific genetic drivers of disease. The company maintains a strong focus on clinical-stage development and strategic collaborations to advance its portfolio of next-generation medicines.

Recent filings

Filing Released Lang Actions
港股公告：翌日披露报表
Transaction in Own Shares Classification · 95% confidence The document is a detailed disclosure report about changes in issued shares and treasury shares, including share issuance due to a director exercising options, and compliance with Hong Kong Stock Exchange Listing Rules (Main Board and GEM). It includes specific dates, share counts, prices, and confirmations of compliance with regulatory requirements. The document is titled as a "翌日披露報表" (Next Day Disclosure Report) and references Hong Kong Listing Rules sections 13.25A and 17.27A, which pertain to disclosures of share issuance and treasury share transactions. It is not an announcement of a report publication but the actual regulatory disclosure itself. This type of document corresponds to a Transaction in Own Shares (POS) filing, as it reports on share issuance and treasury share movements. The document length is 4032 characters, which is sufficient for a detailed disclosure but not a full financial report. Therefore, the correct classification is POS with high confidence.
2025-04-15 Chinese
港股公告：证券变动月报表
Share Issue/Capital Change Classification · 95% confidence The document is a monthly securities movement report submitted to the Hong Kong Stock Exchange, detailing changes in issued shares, share options exercised, and other share capital movements for the period ending March 31, 2025. It includes detailed tables of share capital changes, share option plans, and confirmations of compliance with listing rules. The document is titled as a "securities movement monthly report" and is a regulatory filing related to share capital changes but does not constitute a full financial report, earnings release, or management discussion. It is not an announcement of a report publication but the report itself of share capital movements. This fits the category of Share Issue/Capital Change (SHA) filings, which cover announcements regarding new share issues, stock splits, or other capital changes. The document length (5562 characters) supports it being a substantive report rather than a brief announcement. Therefore, the appropriate classification is SHA with high confidence.
2025-04-08 Chinese
港股公告：授出受限制股份单位
Regulatory Filings Classification · 95% confidence The document is a formal announcement regarding the grant of restricted stock units (RSUs) under the company's 2016 Option and Incentive Plan. It details the number of shares granted, the vesting schedule, the recipients, and the rationale behind the grant. The document references compliance with listing rules and includes definitions and explanations related to the stock units. There is no financial statement, earnings data, or management discussion of financial results. It is not a report but an announcement of a share-based compensation grant. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about share-based awards and does not fit other more specific categories like Remuneration Information (DEF 14A) because it is not a detailed compensation report but a grant announcement under listing rules. The document length is short (2715 characters), and it is a standalone announcement rather than a report or presentation.
2025-04-08 Chinese
百济神州有限公司2025年年度股东大会会议资料
AGM Information Classification · 100% confidence The document is a detailed circular and notice related to the 2025 Annual General Meeting (AGM) of BeiGene Ltd. It includes extensive information about the company's achievements, strategic plans, and detailed proposals to be voted on at the AGM, such as director elections, auditor appointments, share issuance and buyback authorizations, and executive compensation advisory votes. The document also contains instructions on voting procedures, shareholder rights, and legal compliance with Hong Kong and Shanghai stock exchange rules. The presence of detailed AGM materials, including the agenda, resolutions, and proxy forms, clearly identifies this as AGM Information. The document is lengthy (15,000 characters) and contains the actual meeting materials, not just an announcement or a brief summary, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the correct classification is AGM Information (AGM-R).
2025-04-07 Chinese
百济神州有限公司关于召开2025年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2025 Annual General Meeting (AGM) of 百济神州有限公司 (Beigene Ltd.). It includes information about the date, voting methods, meeting agenda items, shareholder eligibility, and proxy voting instructions. The content focuses on the logistics and procedural details of the AGM rather than presenting financial results, management discussion, or audit opinions. There is no financial data or report attached, nor is it an announcement of a report publication. The document is clearly a notice and materials related to the Annual General Meeting itself, which fits the definition of AGM Information (AGM-R). The document length is under 5,000 characters, but it is not merely an announcement of a report publication; it contains substantive AGM details and agenda items. Therefore, the correct classification is AGM Information (AGM-R).
2025-04-07 Chinese
港股公告：翌日披露报表
Share Issue/Capital Change Classification · 100% confidence The document is a detailed disclosure report about changes in issued shares and treasury shares of a listed company, including share issuance under share plans and share repurchases, with references to Hong Kong Stock Exchange Listing Rules (Main Board and GEM). It includes specific dates, share counts, prices, and confirmations of compliance with listing rules. The document is not an announcement of a report but the actual disclosure itself, containing substantive data on share capital changes. This matches the definition of a Share Issue/Capital Change filing, which covers announcements regarding new share issues, stock splits, or other capital changes. The document is 4547 characters long, sufficient to be a full disclosure rather than a brief announcement. Therefore, the correct classification is SHA (Share Issue/Capital Change).
2025-04-01 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.